The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Continuous Subcutaneous Insulin Infusion Therapy Market Research Report 2025

Global Continuous Subcutaneous Insulin Infusion Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1721954

No of Pages : 71

Ask Your Query
Synopsis
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin infusion therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries); a disposable reservoir for insulin (inside the pump) a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to interface the insulin reservoir to the cannula. Other configurations are possible. For instance, more recent models may include disposable or semi-disposable designs for the pumping mechanism and may eliminate tubing from the infusion set.
The global Continuous Subcutaneous Insulin Infusion Therapy market was valued at US$ 714 million in 2023 and is anticipated to reach US$ 1210 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Continuous Subcutaneous Insulin Infusion Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Subcutaneous Insulin Infusion Therapy.
Report Scope
The Continuous Subcutaneous Insulin Infusion Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Continuous Subcutaneous Insulin Infusion Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Subcutaneous Insulin Infusion Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Roche
SOOIL
Tandem Diabetes care
Insulet Corp
Valeritas
Microport
Segment by Type
Normal
Patch Pump
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Continuous Subcutaneous Insulin Infusion Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Normal
1.2.3 Patch Pump
1.3 Market by Application
1.3.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Perspective (2019-2030)
2.2 Continuous Subcutaneous Insulin Infusion Therapy Growth Trends by Region
2.2.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Continuous Subcutaneous Insulin Infusion Therapy Historic Market Size by Region (2019-2024)
2.2.3 Continuous Subcutaneous Insulin Infusion Therapy Forecasted Market Size by Region (2025-2030)
2.3 Continuous Subcutaneous Insulin Infusion Therapy Market Dynamics
2.3.1 Continuous Subcutaneous Insulin Infusion Therapy Industry Trends
2.3.2 Continuous Subcutaneous Insulin Infusion Therapy Market Drivers
2.3.3 Continuous Subcutaneous Insulin Infusion Therapy Market Challenges
2.3.4 Continuous Subcutaneous Insulin Infusion Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Continuous Subcutaneous Insulin Infusion Therapy Players by Revenue
3.1.1 Global Top Continuous Subcutaneous Insulin Infusion Therapy Players by Revenue (2019-2024)
3.1.2 Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Continuous Subcutaneous Insulin Infusion Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Continuous Subcutaneous Insulin Infusion Therapy Revenue
3.4 Global Continuous Subcutaneous Insulin Infusion Therapy Market Concentration Ratio
3.4.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Continuous Subcutaneous Insulin Infusion Therapy Revenue in 2023
3.5 Continuous Subcutaneous Insulin Infusion Therapy Key Players Head office and Area Served
3.6 Key Players Continuous Subcutaneous Insulin Infusion Therapy Product Solution and Service
3.7 Date of Enter into Continuous Subcutaneous Insulin Infusion Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Continuous Subcutaneous Insulin Infusion Therapy Breakdown Data by Type
4.1 Global Continuous Subcutaneous Insulin Infusion Therapy Historic Market Size by Type (2019-2024)
4.2 Global Continuous Subcutaneous Insulin Infusion Therapy Forecasted Market Size by Type (2025-2030)
5 Continuous Subcutaneous Insulin Infusion Therapy Breakdown Data by Application
5.1 Global Continuous Subcutaneous Insulin Infusion Therapy Historic Market Size by Application (2019-2024)
5.2 Global Continuous Subcutaneous Insulin Infusion Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Continuous Subcutaneous Insulin Infusion Therapy Market Size (2019-2030)
6.2 North America Continuous Subcutaneous Insulin Infusion Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2019-2024)
6.4 North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size (2019-2030)
7.2 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2019-2024)
7.4 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Continuous Subcutaneous Insulin Infusion Therapy Market Size (2019-2030)
8.2 Asia-Pacific Continuous Subcutaneous Insulin Infusion Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Continuous Subcutaneous Insulin Infusion Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Continuous Subcutaneous Insulin Infusion Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size (2019-2030)
9.2 Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2019-2024)
9.4 Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Continuous Subcutaneous Insulin Infusion Therapy Market Size (2019-2030)
10.2 Middle East & Africa Continuous Subcutaneous Insulin Infusion Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Therapy Introduction
11.1.4 Medtronic Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
11.1.5 Medtronic Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Continuous Subcutaneous Insulin Infusion Therapy Introduction
11.2.4 Roche Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
11.2.5 Roche Recent Development
11.3 SOOIL
11.3.1 SOOIL Company Detail
11.3.2 SOOIL Business Overview
11.3.3 SOOIL Continuous Subcutaneous Insulin Infusion Therapy Introduction
11.3.4 SOOIL Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
11.3.5 SOOIL Recent Development
11.4 Tandem Diabetes care
11.4.1 Tandem Diabetes care Company Detail
11.4.2 Tandem Diabetes care Business Overview
11.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Therapy Introduction
11.4.4 Tandem Diabetes care Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
11.4.5 Tandem Diabetes care Recent Development
11.5 Insulet Corp
11.5.1 Insulet Corp Company Detail
11.5.2 Insulet Corp Business Overview
11.5.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Therapy Introduction
11.5.4 Insulet Corp Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
11.5.5 Insulet Corp Recent Development
11.6 Valeritas
11.6.1 Valeritas Company Detail
11.6.2 Valeritas Business Overview
11.6.3 Valeritas Continuous Subcutaneous Insulin Infusion Therapy Introduction
11.6.4 Valeritas Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
11.6.5 Valeritas Recent Development
11.7 Microport
11.7.1 Microport Company Detail
11.7.2 Microport Business Overview
11.7.3 Microport Continuous Subcutaneous Insulin Infusion Therapy Introduction
11.7.4 Microport Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
11.7.5 Microport Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock